We found that the mean levels of CCL21 in anti-CCL21 antibody positive patients were 0.49 ± 0.59 ng/ml, 0.33 ± 0.10 ng/ml and 0.33 ± 0.09 ng/ml for SSc, SS and MCTD respectively. Here, CCL21 is linked to systemic sclerosis.